 | • レポートコード：MRC2-11QY14547 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は腎盂腎炎治療薬のグローバル市場について調査・分析したレポートです。種類別（フィナフロキサシン、ホスホマイシントロメタミン、ナクバクタム、硫酸プラゾマイシン、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別腎盂腎炎治療薬の競争状況、市場シェア ・世界の腎盂腎炎治療薬市場：種類別市場規模 2015年-2020年（フィナフロキサシン、ホスホマイシントロメタミン、ナクバクタム、硫酸プラゾマイシン、その他） ・世界の腎盂腎炎治療薬市場：種類別市場規模予測 2021年-2026年（フィナフロキサシン、ホスホマイシントロメタミン、ナクバクタム、硫酸プラゾマイシン、その他） ・世界の腎盂腎炎治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の腎盂腎炎治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の腎盂腎炎治療薬市場分析：米国、カナダ ・ヨーロッパの腎盂腎炎治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの腎盂腎炎治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の腎盂腎炎治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの腎盂腎炎治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Achaogen Inc、AstraZeneca Plc、Meiji Seika Pharma Co Ltd、Merck & Co Inc、MerLion Pharmaceuticals Pte Ltd、The Medicines Company、Zavante Therapeutics Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Pyelonephritis Drug Market
The global Pyelonephritis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Pyelonephritis Drug Scope and Market Size
Pyelonephritis Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pyelonephritis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Pyelonephritis Drug market is segmented into
Finafloxacin
Fosfomycin Tromethamine
Nacubactam
Plazomicin Sulfate
Others
Segment by Application, the Pyelonephritis Drug market is segmented into
Hospital
Clinic
Others
Regional and Country-level Analysis
The Pyelonephritis Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pyelonephritis Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pyelonephritis Drug Market Share Analysis
Pyelonephritis Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pyelonephritis Drug business, the date to enter into the Pyelonephritis Drug market, Pyelonephritis Drug product introduction, recent developments, etc.
The major vendors covered:
Achaogen Inc
AstraZeneca Plc
Meiji Seika Pharma Co Ltd
Merck & Co Inc
MerLion Pharmaceuticals Pte Ltd
The Medicines Company
Zavante Therapeutics Inc
…
1 Study Coverage
1.1 Pyelonephritis Drug Product Introduction
1.2 Market Segments
1.3 Key Pyelonephritis Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pyelonephritis Drug Market Size Growth Rate by Type
1.4.2 Finafloxacin
1.4.3 Fosfomycin Tromethamine
1.4.4 Nacubactam
1.4.5 Plazomicin Sulfate
1.4.6 Others
1.5 Market by Application
1.5.1 Global Pyelonephritis Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pyelonephritis Drug Market Size, Estimates and Forecasts
2.1.1 Global Pyelonephritis Drug Revenue 2015-2026
2.1.2 Global Pyelonephritis Drug Sales 2015-2026
2.2 Global Pyelonephritis Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Pyelonephritis Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Pyelonephritis Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Pyelonephritis Drug Competitor Landscape by Players
3.1 Pyelonephritis Drug Sales by Manufacturers
3.1.1 Pyelonephritis Drug Sales by Manufacturers (2015-2020)
3.1.2 Pyelonephritis Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Pyelonephritis Drug Revenue by Manufacturers
3.2.1 Pyelonephritis Drug Revenue by Manufacturers (2015-2020)
3.2.2 Pyelonephritis Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pyelonephritis Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pyelonephritis Drug Revenue in 2019
3.2.5 Global Pyelonephritis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Pyelonephritis Drug Price by Manufacturers
3.4 Pyelonephritis Drug Manufacturing Base Distribution, Product Types
3.4.1 Pyelonephritis Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pyelonephritis Drug Product Type
3.4.3 Date of International Manufacturers Enter into Pyelonephritis Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pyelonephritis Drug Market Size by Type (2015-2020)
4.1.1 Global Pyelonephritis Drug Sales by Type (2015-2020)
4.1.2 Global Pyelonephritis Drug Revenue by Type (2015-2020)
4.1.3 Pyelonephritis Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pyelonephritis Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Pyelonephritis Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Pyelonephritis Drug Revenue Forecast by Type (2021-2026)
4.2.3 Pyelonephritis Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pyelonephritis Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Pyelonephritis Drug Market Size by Application (2015-2020)
5.1.1 Global Pyelonephritis Drug Sales by Application (2015-2020)
5.1.2 Global Pyelonephritis Drug Revenue by Application (2015-2020)
5.1.3 Pyelonephritis Drug Price by Application (2015-2020)
5.2 Pyelonephritis Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Pyelonephritis Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Pyelonephritis Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Pyelonephritis Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Pyelonephritis Drug by Country
6.1.1 North America Pyelonephritis Drug Sales by Country
6.1.2 North America Pyelonephritis Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Pyelonephritis Drug Market Facts & Figures by Type
6.3 North America Pyelonephritis Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Pyelonephritis Drug by Country
7.1.1 Europe Pyelonephritis Drug Sales by Country
7.1.2 Europe Pyelonephritis Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pyelonephritis Drug Market Facts & Figures by Type
7.3 Europe Pyelonephritis Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Pyelonephritis Drug by Region
8.1.1 Asia Pacific Pyelonephritis Drug Sales by Region
8.1.2 Asia Pacific Pyelonephritis Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Pyelonephritis Drug Market Facts & Figures by Type
8.3 Asia Pacific Pyelonephritis Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Pyelonephritis Drug by Country
9.1.1 Latin America Pyelonephritis Drug Sales by Country
9.1.2 Latin America Pyelonephritis Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Pyelonephritis Drug Market Facts & Figures by Type
9.3 Central & South America Pyelonephritis Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Pyelonephritis Drug by Country
10.1.1 Middle East and Africa Pyelonephritis Drug Sales by Country
10.1.2 Middle East and Africa Pyelonephritis Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Pyelonephritis Drug Market Facts & Figures by Type
10.3 Middle East and Africa Pyelonephritis Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Achaogen Inc
11.1.1 Achaogen Inc Corporation Information
11.1.2 Achaogen Inc Description and Business Overview
11.1.3 Achaogen Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Achaogen Inc Pyelonephritis Drug Products Offered
11.1.5 Achaogen Inc Related Developments
11.2 AstraZeneca Plc
11.2.1 AstraZeneca Plc Corporation Information
11.2.2 AstraZeneca Plc Description and Business Overview
11.2.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AstraZeneca Plc Pyelonephritis Drug Products Offered
11.2.5 AstraZeneca Plc Related Developments
11.3 Meiji Seika Pharma Co Ltd
11.3.1 Meiji Seika Pharma Co Ltd Corporation Information
11.3.2 Meiji Seika Pharma Co Ltd Description and Business Overview
11.3.3 Meiji Seika Pharma Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Meiji Seika Pharma Co Ltd Pyelonephritis Drug Products Offered
11.3.5 Meiji Seika Pharma Co Ltd Related Developments
11.4 Merck & Co Inc
11.4.1 Merck & Co Inc Corporation Information
11.4.2 Merck & Co Inc Description and Business Overview
11.4.3 Merck & Co Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck & Co Inc Pyelonephritis Drug Products Offered
11.4.5 Merck & Co Inc Related Developments
11.5 MerLion Pharmaceuticals Pte Ltd
11.5.1 MerLion Pharmaceuticals Pte Ltd Corporation Information
11.5.2 MerLion Pharmaceuticals Pte Ltd Description and Business Overview
11.5.3 MerLion Pharmaceuticals Pte Ltd Sales, Revenue and Gross Margin (2015-2020)
11.5.4 MerLion Pharmaceuticals Pte Ltd Pyelonephritis Drug Products Offered
11.5.5 MerLion Pharmaceuticals Pte Ltd Related Developments
11.6 The Medicines Company
11.6.1 The Medicines Company Corporation Information
11.6.2 The Medicines Company Description and Business Overview
11.6.3 The Medicines Company Sales, Revenue and Gross Margin (2015-2020)
11.6.4 The Medicines Company Pyelonephritis Drug Products Offered
11.6.5 The Medicines Company Related Developments
11.7 Zavante Therapeutics Inc
11.7.1 Zavante Therapeutics Inc Corporation Information
11.7.2 Zavante Therapeutics Inc Description and Business Overview
11.7.3 Zavante Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Zavante Therapeutics Inc Pyelonephritis Drug Products Offered
11.7.5 Zavante Therapeutics Inc Related Developments
11.1 Achaogen Inc
11.1.1 Achaogen Inc Corporation Information
11.1.2 Achaogen Inc Description and Business Overview
11.1.3 Achaogen Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Achaogen Inc Pyelonephritis Drug Products Offered
11.1.5 Achaogen Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Pyelonephritis Drug Market Estimates and Projections by Region
12.1.1 Global Pyelonephritis Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Pyelonephritis Drug Revenue Forecast by Regions 2021-2026
12.2 North America Pyelonephritis Drug Market Size Forecast (2021-2026)
12.2.1 North America: Pyelonephritis Drug Sales Forecast (2021-2026)
12.2.2 North America: Pyelonephritis Drug Revenue Forecast (2021-2026)
12.2.3 North America: Pyelonephritis Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Pyelonephritis Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Pyelonephritis Drug Sales Forecast (2021-2026)
12.3.2 Europe: Pyelonephritis Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Pyelonephritis Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Pyelonephritis Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Pyelonephritis Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Pyelonephritis Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Pyelonephritis Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Pyelonephritis Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Pyelonephritis Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Pyelonephritis Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Pyelonephritis Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Pyelonephritis Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Pyelonephritis Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Pyelonephritis Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Pyelonephritis Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Pyelonephritis Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pyelonephritis Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Pyelonephritis Drug Market Segments
Table 2. Ranking of Global Top Pyelonephritis Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pyelonephritis Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Finafloxacin
Table 5. Major Manufacturers of Fosfomycin Tromethamine
Table 6. Major Manufacturers of Nacubactam
Table 7. Major Manufacturers of Plazomicin Sulfate
Table 8. Major Manufacturers of Others
Table 9. Global Pyelonephritis Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Pyelonephritis Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Pyelonephritis Drug Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Pyelonephritis Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Pyelonephritis Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Pyelonephritis Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Pyelonephritis Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Pyelonephritis Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Pyelonephritis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pyelonephritis Drug as of 2019)
Table 18. Pyelonephritis Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Pyelonephritis Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Pyelonephritis Drug Price (2015-2020) (USD/Pcs)
Table 21. Pyelonephritis Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Pyelonephritis Drug Product Type
Table 23. Date of International Manufacturers Enter into Pyelonephritis Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Pyelonephritis Drug Sales by Type (2015-2020) (K Pcs)
Table 26. Global Pyelonephritis Drug Sales Share by Type (2015-2020)
Table 27. Global Pyelonephritis Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Pyelonephritis Drug Revenue Share by Type (2015-2020)
Table 29. Pyelonephritis Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Pyelonephritis Drug Sales by Application (2015-2020) (K Pcs)
Table 31. Global Pyelonephritis Drug Sales Share by Application (2015-2020)
Table 32. North America Pyelonephritis Drug Sales by Country (2015-2020) (K Pcs)
Table 33. North America Pyelonephritis Drug Sales Market Share by Country (2015-2020)
Table 34. North America Pyelonephritis Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Pyelonephritis Drug Revenue Market Share by Country (2015-2020)
Table 36. North America Pyelonephritis Drug Sales by Type (2015-2020) (K Pcs)
Table 37. North America Pyelonephritis Drug Sales Market Share by Type (2015-2020)
Table 38. North America Pyelonephritis Drug Sales by Application (2015-2020) (K Pcs)
Table 39. North America Pyelonephritis Drug Sales Market Share by Application (2015-2020)
Table 40. Europe Pyelonephritis Drug Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Pyelonephritis Drug Sales Market Share by Country (2015-2020)
Table 42. Europe Pyelonephritis Drug Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Pyelonephritis Drug Revenue Market Share by Country (2015-2020)
Table 44. Europe Pyelonephritis Drug Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Pyelonephritis Drug Sales Market Share by Type (2015-2020)
Table 46. Europe Pyelonephritis Drug Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Pyelonephritis Drug Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Pyelonephritis Drug Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Pyelonephritis Drug Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Pyelonephritis Drug Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Pyelonephritis Drug Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Pyelonephritis Drug Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Pyelonephritis Drug Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Pyelonephritis Drug Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Pyelonephritis Drug Sales Market Share by Application (2015-2020)
Table 56. Latin America Pyelonephritis Drug Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Pyelonephritis Drug Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Pyelonephritis Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Pyelonephritis Drug Revenue Market Share by Country (2015-2020)
Table 60. Latin America Pyelonephritis Drug Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Pyelonephritis Drug Sales Market Share by Type (2015-2020)
Table 62. Latin America Pyelonephritis Drug Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Pyelonephritis Drug Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Pyelonephritis Drug Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Pyelonephritis Drug Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Pyelonephritis Drug Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Pyelonephritis Drug Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Pyelonephritis Drug Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Pyelonephritis Drug Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Pyelonephritis Drug Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Pyelonephritis Drug Sales Market Share by Application (2015-2020)
Table 72. Achaogen Inc Corporation Information
Table 73. Achaogen Inc Description and Major Businesses
Table 74. Achaogen Inc Pyelonephritis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Achaogen Inc Product
Table 76. Achaogen Inc Recent Development
Table 77. AstraZeneca Plc Corporation Information
Table 78. AstraZeneca Plc Description and Major Businesses
Table 79. AstraZeneca Plc Pyelonephritis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. AstraZeneca Plc Product
Table 81. AstraZeneca Plc Recent Development
Table 82. Meiji Seika Pharma Co Ltd Corporation Information
Table 83. Meiji Seika Pharma Co Ltd Description and Major Businesses
Table 84. Meiji Seika Pharma Co Ltd Pyelonephritis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Meiji Seika Pharma Co Ltd Product
Table 86. Meiji Seika Pharma Co Ltd Recent Development
Table 87. Merck & Co Inc Corporation Information
Table 88. Merck & Co Inc Description and Major Businesses
Table 89. Merck & Co Inc Pyelonephritis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Merck & Co Inc Product
Table 91. Merck & Co Inc Recent Development
Table 92. MerLion Pharmaceuticals Pte Ltd Corporation Information
Table 93. MerLion Pharmaceuticals Pte Ltd Description and Major Businesses
Table 94. MerLion Pharmaceuticals Pte Ltd Pyelonephritis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. MerLion Pharmaceuticals Pte Ltd Product
Table 96. MerLion Pharmaceuticals Pte Ltd Recent Development
Table 97. The Medicines Company Corporation Information
Table 98. The Medicines Company Description and Major Businesses
Table 99. The Medicines Company Pyelonephritis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. The Medicines Company Product
Table 101. The Medicines Company Recent Development
Table 102. Zavante Therapeutics Inc Corporation Information
Table 103. Zavante Therapeutics Inc Description and Major Businesses
Table 104. Zavante Therapeutics Inc Pyelonephritis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Zavante Therapeutics Inc Product
Table 106. Zavante Therapeutics Inc Recent Development
Table 107. Global Pyelonephritis Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 108. Global Pyelonephritis Drug Sales Market Share Forecast by Regions (2021-2026)
Table 109. Global Pyelonephritis Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 110. Global Pyelonephritis Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 111. North America: Pyelonephritis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 112. North America: Pyelonephritis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Europe: Pyelonephritis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 114. Europe: Pyelonephritis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Asia Pacific: Pyelonephritis Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 116. Asia Pacific: Pyelonephritis Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 117. Latin America: Pyelonephritis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 118. Latin America: Pyelonephritis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Middle East and Africa: Pyelonephritis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 120. Middle East and Africa: Pyelonephritis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 122. Key Challenges
Table 123. Market Risks
Table 124. Main Points Interviewed from Key Pyelonephritis Drug Players
Table 125. Pyelonephritis Drug Customers List
Table 126. Pyelonephritis Drug Distributors List
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Pyelonephritis Drug Product Picture
Figure 2. Global Pyelonephritis Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Finafloxacin Product Picture
Figure 4. Fosfomycin Tromethamine Product Picture
Figure 5. Nacubactam Product Picture
Figure 6. Plazomicin Sulfate Product Picture
Figure 7. Others Product Picture
Figure 8. Global Pyelonephritis Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Pyelonephritis Drug Report Years Considered
Figure 13. Global Pyelonephritis Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Pyelonephritis Drug Sales 2015-2026 (K Pcs)
Figure 15. Global Pyelonephritis Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Pyelonephritis Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Pyelonephritis Drug Sales Market Share by Region in 2019
Figure 18. Global Pyelonephritis Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Pyelonephritis Drug Revenue Market Share by Region in 2019
Figure 20. Global Pyelonephritis Drug Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Pyelonephritis Drug Revenue in 2019
Figure 22. Pyelonephritis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Pyelonephritis Drug Sales Market Share by Type (2015-2020)
Figure 24. Global Pyelonephritis Drug Sales Market Share by Type in 2019
Figure 25. Global Pyelonephritis Drug Revenue Market Share by Type (2015-2020)
Figure 26. Global Pyelonephritis Drug Revenue Market Share by Type in 2019
Figure 27. Global Pyelonephritis Drug Market Share by Price Range (2015-2020)
Figure 28. Global Pyelonephritis Drug Sales Market Share by Application (2015-2020)
Figure 29. Global Pyelonephritis Drug Sales Market Share by Application in 2019
Figure 30. Global Pyelonephritis Drug Revenue Market Share by Application (2015-2020)
Figure 31. Global Pyelonephritis Drug Revenue Market Share by Application in 2019
Figure 32. North America Pyelonephritis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Pyelonephritis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Pyelonephritis Drug Sales Market Share by Country in 2019
Figure 35. North America Pyelonephritis Drug Revenue Market Share by Country in 2019
Figure 36. U.S. Pyelonephritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Pyelonephritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Pyelonephritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Pyelonephritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Pyelonephritis Drug Market Share by Type in 2019
Figure 41. North America Pyelonephritis Drug Market Share by Application in 2019
Figure 42. Europe Pyelonephritis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Pyelonephritis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Pyelonephritis Drug Sales Market Share by Country in 2019
Figure 45. Europe Pyelonephritis Drug Revenue Market Share by Country in 2019
Figure 46. Germany Pyelonephritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Pyelonephritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Pyelonephritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Pyelonephritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Pyelonephritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Pyelonephritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Pyelonephritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Pyelonephritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Pyelonephritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Pyelonephritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Pyelonephritis Drug Market Share by Type in 2019
Figure 57. Europe Pyelonephritis Drug Market Share by Application in 2019
Figure 58. Asia Pacific Pyelonephritis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Pyelonephritis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Pyelonephritis Drug Sales Market Share by Region in 2019
Figure 61. Asia Pacific Pyelonephritis Drug Revenue Market Share by Region in 2019
Figure 62. China Pyelonephritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Pyelonephritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Pyelonephritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Pyelonephritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Pyelonephritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Pyelonephritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Pyelonephritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Pyelonephritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Pyelonephritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Pyelonephritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Pyelonephritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Pyelonephritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Pyelonephritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Pyelonephritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Pyelonephritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Pyelonephritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Pyelonephritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Pyelonephritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Pyelonephritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Pyelonephritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Pyelonephritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Pyelonephritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Pyelonephritis Drug Market Share by Type in 2019
Figure 85. Asia Pacific Pyelonephritis Drug Market Share by Application in 2019
Figure 86. Latin America Pyelonephritis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Pyelonephritis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Pyelonephritis Drug Sales Market Share by Country in 2019
Figure 89. Latin America Pyelonephritis Drug Revenue Market Share by Country in 2019
Figure 90. Mexico Pyelonephritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Pyelonephritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Pyelonephritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Pyelonephritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Pyelonephritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Pyelonephritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Pyelonephritis Drug Market Share by Type in 2019
Figure 97. Latin America Pyelonephritis Drug Market Share by Application in 2019
Figure 98. Middle East and Africa Pyelonephritis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Pyelonephritis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Pyelonephritis Drug Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Pyelonephritis Drug Revenue Market Share by Country in 2019
Figure 102. Turkey Pyelonephritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Pyelonephritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Pyelonephritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Pyelonephritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Pyelonephritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Pyelonephritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Pyelonephritis Drug Market Share by Type in 2019
Figure 109. Middle East and Africa Pyelonephritis Drug Market Share by Application in 2019
Figure 110. North America Pyelonephritis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Pyelonephritis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Pyelonephritis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Pyelonephritis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Pyelonephritis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Pyelonephritis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Pyelonephritis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Pyelonephritis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Pyelonephritis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Pyelonephritis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
小売薬の世界市場（～2026年） A drug is any substance (other than food that provides nutritional support) that, when inhaled, injected, smoked, consumed, absorbed via a patch on the skin, or dissolved under the tongue causes a temporary physiological (and often psychological) change in the body. Increasing industry share of Asia…- 大麻薬の世界市場（～2026年） Drugs with chemicals taken directly from the marijuana plant，or with synthetic versions of chemicals naturally found in marijuana. Market Analysis and Insights: Global Cannabis Drug Market The global Cannabis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020,…
- 乱用薬物検査サービスの世界市場（～2026年） Drug of Abuse Testing Services is the use of testing services to avoid the negative effects of drug abuse, to reduce the accidents. In addition to rise in number of substance abusers and increase in number of government initiatives to avoid ill effects of substance abuse at workplace & reduce number…
- 薬物スクリーニング検査サービスの世界市場（～2026年） Market Analysis and Insights: Global Drug Screening Laboratory Service Market The global Drug Screening Laboratory Service market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high da…
- 子宮内膜ポリープ治療薬の世界市場（～2026年） Uterine polyps are common gynecological diseases. Broadly speaking, it refers to all tumors attached to the uterine wall by slender pedicle. Mostly benign. Market Analysis and Insights: Global Uterine Polyps Drug Market The global Uterine Polyps Drug market size is projected to reach US$ XX million …